{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "DKK", "marketState": "POSTPOST", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -3.8079474, "regularMarketPrice": 1.162, "exchange": "CPH", "shortName": "Orphazyme A/S", "longName": "Orphazyme A/S", "messageBoardId": "finmb_99715906", "exchangeTimezoneName": "Europe/Copenhagen", "market": "dk_market", "regularMarketTime": 1683902739, "regularMarketDayHigh": 1.232, "regularMarketDayRange": "1.16 - 1.232", "regularMarketDayLow": 1.16, "regularMarketVolume": 52813, "regularMarketPreviousClose": 1.208, "bid": 1.16, "ask": 1.198, "bidSize": 0, "askSize": 0, "fullExchangeName": "Copenhagen", "financialCurrency": "DKK", "regularMarketOpen": 1.2, "averageDailyVolume3Month": 253382, "averageDailyVolume10Day": 1004735, "fiftyTwoWeekLowChange": 0.48699993, "fiftyTwoWeekLowChangePercent": 0.7214814, "fiftyTwoWeekRange": "0.675 - 2.53", "fiftyTwoWeekHighChange": -1.368, "fiftyTwoWeekHighChangePercent": -0.54071146, "fiftyTwoWeekLow": 0.675, "fiftyTwoWeekHigh": 2.53, "earningsTimestamp": 1680017124, "earningsTimestampStart": 1680017124, "earningsTimestampEnd": 1680017124, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -18.29, "epsForward": -5.4, "sharesOutstanding": 35312200, "bookValue": 1.181, "fiftyDayAverage": 0.87866, "fiftyDayAverageChange": 0.28333992, "fiftyDayAverageChangePercent": 0.3224682, "twoHundredDayAverage": 1.1007324, "twoHundredDayAverageChange": 0.061267495, "twoHundredDayAverageChangePercent": 0.05566066, "marketCap": 41032776, "forwardPE": -0.21518517, "priceToBook": 0.9839119, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1511251200000, "priceHint": 4, "regularMarketChange": -0.046000004, "symbol": "ORPHA.CO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ole Maal\u00f8es Vej 3", "city": "Copenhagen", "zip": "2200", "country": "Denmark", "phone": "45 70 70 29 80", "website": "https://www.orphazyme.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Anders Fink Vadsholt M.B.A., M.Sc., MBA", "age": 53, "title": "CEO, CFO & Director", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 7567000, "fmt": "7.57M", "longFmt": "7,567,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Jennifer Jean McCann", "title": "Pres of Orphazyme US, Inc.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}